Showing results (451-460 of 586) with videos related to

Sort By:
Pageof 59
American Heart Journal|February 3, 2009
Standardizing care for acute decompensated heart failure in a large megatrial: the approach for the Acute Studies of Clinical Effectiveness of Nesiritide in Subjects with Decompensated Heart Failure (ASCEND-HF)Justin A Ezekowitz, Adrian F Hernandez, Randall C Starling, et al.
Pediatrics|January 16, 2020
Big Data in the Assessment of Pediatric Medication SafetyAnn W McMahon, William O Cooper, Jeffrey S Brown, et al.
Pediatric Hematology and Oncology|August 3, 2010
Transfusion and chelation practices in sickle cell disease: a regional perspectiveElliott P Vichinsky, Kwaku Ohene-Frempong, Swee Lay Thein, et al.
The American Journal of Cardiology|February 22, 2005
Comparison of ST-segment resolution with combined fibrinolytic and glycoprotein IIb/IIIa inhibitor therapy versus fibrinolytic alone (data from four clinical trials)Abdallah G Rebeiz, Per Johanson, Cindy L Green, et al.
JACC. Heart Failure|October 10, 2015
Circulating Kidney Injury Molecule-1 Levels in Acute Heart Failure: Insights From the ASCEND-HF Trial (Acute Study of Clinical Effectiveness of Nesiritide in Decompensated Heart Failure)Justin L Grodin, Antonio L Perez, Yuping Wu, et al.
Circulation. Cardiovascular Quality and Outcomes|February 10, 2011
The impact of postrandomization crossover of therapy in acute coronary syndromes careKenneth W Mahaffey, Karen S Pieper, Yuliya Lokhnygina, et al.
Lancet (London, England)|March 10, 2015
Digoxin use in patients with atrial fibrillation and adverse cardiovascular outcomes: a retrospective analysis of the Rivaroxaban Once Daily Oral Direct Factor Xa Inhibition Compared with Vitamin K Antagonism for Prevention of Stroke and Embolism Trial in Atrial Fibrillation (ROCKET AF)Jeffrey B Washam, Susanna R Stevens, Yuliya Lokhnygina, et al.
American Heart Journal|December 18, 2002
Promise of combined low-molecular-weight heparin and platelet glycoprotein IIb/IIIa inhibition: results from Platelet IIb/IIIa Antagonist for the Reduction of Acute coronary syndrome events in a Global Organization Network B (PARAGON B)Debabrata Mukherjee, Kenneth W Mahaffey, David J Moliterno, et al.
Vascular Medicine (London, England)|June 20, 2012
An evidence-based score to detect prevalent peripheral artery disease (PAD)Sue Duval, Joseph M Massaro, Michael R Jaff, et al.
Circulation|July 18, 2002
Sustained ventricular arrhythmias among patients with acute coronary syndromes with no ST-segment elevation: incidence, predictors, and outcomesSana M Al-Khatib, Christopher B Granger, Yao Huang, et al.
Pageof 59